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Acute Elevation of Blood Carboxyhemoglobin to 6% Impairs Exercise
Performance and Aggravates Symptoms in Patients With Ischemic
Heart Disease
KIRKWOOD F. ADAMS, MD, GARY KOCH, PHD, BENU CHATTERJEE, MD,
GEORGE M. GOLDSTEIN, PHD, JOHN J . O'NEIL, PHD, PHILIP A . BROMBERG, MD,
DAVID S. SHEPS, MD, FACC WITH TECHNICAL ASSISTANCE FROM
SUSAN McALLISTER, CYNTHIA J
. PRICE, JILL BISSETTE
Chapel Hill. North Carolina
Acute exposure to carbon monoxide has the potential to
impair exercise capacity in patients with isdlemic heart
disease. The effect of sufficient inhalation of this compound
to gradually produce a level of 6% carboxyhemoglobin was
studied in 30 nonsmoking patients with obstructive coro-
nary artery disease and evidence of exerelsednduced iseb .
ends
. After an initial training session, subjects were ex-
posed to air or carbon monoxide on successive days in a
randomized double-blind crossover fashion . Cardiac func-
tion and exercise capacity were assessed during symptom-
limited supine radionuclide ventrknlography . On the ear-
bon monoxide day, mean postexposure carboxyhemoglobin
was 5 .9 ± 0
.1% compared with 1 .6 ± 0.1% (p < 0.01) after
air exposure.
The swan duration of exercise was significantly longer
after air compared with carbon monoxide exposure (626 s
Inadequate coronary blood flow during stress in patients
with ischemic heart disease makes optimal function of the
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50 s for air versus 505 ± 49 s for carbon monoxide, p <
0.05), Actuarial methods suggested that subjects were likely
to experience angina earlier during exercise on the day of
carbon monoxide exposure (p < 0 .05) . Both the level (62 ±
2.4 versus 60 ± 2.4%, p = 0.05) and change in left
ventricular ejection fraction at suhmaximal exercise (1 .6 a
1
.6 versus -1.2 t 1 .6%, p = 0.05) were greater no the air
expesureday compared with the carbon monoxide day . The
peak exercise left ventricular ejection fraction was not
different for the two exposures (57 t
2.5% for both)
. These
results demonstrate earlier onset of ventricular dysfune .
tion, angina and poorer exercise performance In patients
with ischemic heart disease after acute carbon monoxide
exposure sufficient to increase blood carbonyhemoglobin to
6%.
(J Am Coll Cordial 1988;12 .908-9)
system for delivery of oxygen to working myocardium
critical. Carbon monoxide has the potential, through its high
affinity for hemoglobin and influence
on
the oxygen dissoci-
ation curve (I), to reduce oxygen transport to cardiac muscle
so that exposure to this compound could enhance myocar-
dial ischemia during vigorous activity in patients with ob-
structive coronary disease . Concern has developed that such
a deleterious cardiac effect might occur at the low levels of
carboxyhemoglobin acquired during the course of ordinary
activities in many areas of the country . Despite extensive
previous investigations (2-14), controversy continues over
whether these concentrations do in fact produce detectable
exercise impairment in patients with ischemic heart disease .
A prior study from this laboratory (15) did not demon-
strate convincing evidence of such effects at a level of 4%
carboxyhemoglobin . The present study extends this work to
an average post-exposure concentration of 6% . Nonsmoking
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patients with coronary artery disease and evidence of exer-
cise-induced ischemia underwent supine bicycle exercise
after double blind exposure to air or carbon monoxide in a
crossover design . Comparative exercise performance after
these exposures was assessed by clinical, electrocardio-
graphic (ECG) and radionuclide variable : . Subjective and
objective indexes of cardiovascular function derived from
these studies indicated a deleterious effect of 6% carboxy-
hemoglobin on patient performance .
Methods
Study patients . Patients for the study protocol were re-
cruited from the inpatient and outpatient cardiology services
of North Carolina Memorial Hospital and by advertisement
in the area surrounding the University . The protocol was
approved by the Institutional Review Board of the Univer-
sity of North Carolina. Written informed consent was ob-
tained from all subjects before participation in the study .
Careful attention was given to the documentation of
coronary artery disease and determination that a history of
exercise-induced ischemia was present to select appropriate
subjects for the study . Criteria for the diagnosis of coronary
artery disease consisted of at least one of the following :
I) Angiographic evidence of coronary artery obstruction
with at least one major vessel having x711% stenosis .
2) Prior myocardial infarction documented by at least two
of the following three criteria: a) chest pain syndrome
consistent with infarction ; b) evolutionary electrocardio-
graphic (ECG) changes; or c) significant elevations of crea-
tine kinase-MB in serum (>2x normal) .
3) History of typical angina or a positive stress test, or
both.
Typical angina was defined as anterior chest, neck or left
arm discomfort brought on by effort and consistently re-
lieved within several minutes by cessation of exercise or
taking sublingual nitroglycerin . For this study, a positive
stress test was defined as horizontal or downsloping ST
depression ml mm at 0 .08 s after the S point during treadmill
exercise or failure of the stress ejection fraction to increase
?5 U from the value at rest during radionuclide testing . In
addition to documentation of coronary artery disease, all
patients scheduled for the training day were required to have
prior evidence of exercise-induced myocardial ischemia .
This was manifested by a history of typical angina or a prior
positive stress test as defined previously .
Patients found during screening to have valvular heart
disease or major systemic illness were not studied . No
patient had uncontrolled hypertension, orthopedic problems
or peripheral vascular disease sufficient to prevent cardiac
symptom-limited bicycle exercise. Anyone screened who
had a history of smoking within the prior 2 months was
excluded from study participation . No patient was found to
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have a pre-exposure venous carboxyhemoglohin concentra-
lion >2.5% during the study .
A (oral ,f42 patirnrs who satisfied the drscrihed criteria
at initial .screening participated in the training day f the
protocol . One patient was excluded after this session be-
cause of poor venous access. Eight patients were eliminated
from further study because of failure to develoo chest pain
consistent with angina or diagnostic ST segmer-, depression
typical of myocardial ischemia during the training exercise .
Four patients without these findings were continued in the
study after alteration of their anginal medication or adjust-
ment of their training day exercise protocol : all four subse-
quently demonstrated evidence of exercise-induced ische-
mia on at least I exposure day and were included in the study
analysis . Three patients, despite abnormalities on the train-
ing day, were later excluded for lack of exercise ischemia on
any of the exposure days . Thus, a final total of30 patients,
all rf,vhom had evidence of exe e-induced ischemia es at
least I exposure day, were included in the study analysis .
Clinical patient characteristics . The analysis group con-
sisted of 22 men and 8 women with a mean age of 58 x I I
years . There were 10 patients who had never smoked and 20
previous smokers in this group . Duration since cessation of
smoking varied from 2 months to 44 years in those with a
history of cigarette use . Coronary artery disease was docu-
mented in 20 patients by a70% stenosis of one or more
major vessels by angiography (7 with one vessel, 7 with two
vessel and 6 with three vessel disease) . Three of the remain-
ing 10 patients had the combination of a positive exercise
test and prior infarction and 6 had a positive exercise test
and angina . Only one patient qualified on the basis of a
positive treadmill test alone . The present study group did not
include any subjects from the previous carbon monoxide
protocol performed in this laboratory .
Antianginal medication was being taken by 25 of
the 30
patients included in the analysis . This consisted of a beta-
adrenergic antagonist alone in six patients, a long-acting
nitrate only in one patient and a calcium channel antagonist
alone in five, There were 13 patients taking both a beta-
adrenergic and a calcium channel antagonist at the rime of
study . Throughout the exposure portion of the study, par-
ticular attention was devoted to ensuring that patients re-
mained on the same doses of their medications and main-
tained precisely the same timing of these doses with relation
to the exercise protocol.
Equipment. Exposure was carried out with the subject
sitting in s chair in an environmentally controlled chamber
measuring 8 x 8 x
7
.5 feet (2
.5 x 2 .5 x 2 .0 m) and
constructed of 314 in . (3 .5
cm) thick plexiglass . Complete air
exchange occurred every
70 s in the chamber . The range of
accuracy for carbon monoxide concentration in this chamber
is ±5% of 100 parts/million (ppm) . The exposure room
temperature was controlled at 77 ± 2° with a humidity of 55
5% .
Experimental protocol. The protocol was carried out over
3 consecutive days (Fig. I) . Day I was a training session
during the first part of which the patient was acquainted with
the protocol and allowed to sit in the exposure chamber for
10 to 20 min . A symptom-limited maximal bicycle exercise
test was then performed . This test was done to minimize any
training effect on subsequent exercise tests and to optimally
tailor the imaging protocol performed on the following 2
days. On days 2 and 3 of the protocol, subjects were exposed
to either pure air or 100 ppm (17 subjects) or 200 ppm (13
subjects) carbon monoxide in a randomized, double-blind
fashion. Venous blood for carboxyhemoglobin determina-
tion was obtained before chamber entry and again after I h of
exposure . On the carbon monoxide day . the duration of
further exposure required to achieve the desired carboxyhe-
moglobin level of 6% was determined privately by a techni-
cian. Became the rate of increase in carboxyhemoglobin is
linear in this range, the technician calculated a venous
carboxyhemoglobin accumulation rate (HbCO%o) for each
patient as follows:
11 h HbCO%l -(initial HbC%l
=IHbC01
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min
increase . This rate of increase was used in conjunction with
the rest carboxyhemoglobin level to determine the duration
of additional exposure necessary to achieve 6% carboxyhe-
moglobin
. Maintenance of double-blind conditions was ac-
complished by following a similar procedure on the air
exposure day . During this session, the duration of additional
exposure after the I h blood sample was determined from a
set of random numbers of plausible magnitude provided to
the technician by the study biostatistician .
At the appropriate time, the patients left the chamber and
underwent rest and exercise radionuclide ventriculography
during air breathing at a temperature of 70 ± 2
° . Additional
venous blood samples were taken at the time of exit from the
chamber . immediately before and after exercise for determi-
nation of carboxyhemoglobin concentration .
Carboxyhemoglobln measurements . The carboxyhemo-
globin levels were measured in triplicate with the use of an
IL 282 Cooximeter
(I6) . Careful standardization studies in
our laboratory have demonstrated that the variance of these
determinations is constant for levels in the range of 6% with
an SEM of 0 .15%
. The technique for carboxyhemoglobin
Figure 1. The study protocol is indicated, outlining activities on each
of 3 consecutive study days . CAD = coronary artery disease ; CO =
carbon monoxide: COH5 = carboxyhemoglobin : Ex = exercise ;
larch = ischemia
: RNV = radionuclide ventriculogmphy .
measurement employed in this study has been carefully
validated against other cooximeter data, the Van Slyke
technique and gas chromatography in cooperation with Dr .
Thomas Dahms and co-workers at St . Louis University
(personal communication) .
Rest hoseline enrhoryltemoglohin concentration deter-
mitted in nonsmoking subjects in our laboratory has a mean
value of 1 .7 ± 0 .1% SEM . This level is relatively high
compared with results of some previous studies but is within
the range of nonsmoking subjects described by Stewart et al .
(17)
.
In that study, the percent of subjects with a level > I to
1 .2% varied from 18 to 76% in various parts of the United
States .
Exercise protocol. All exercise tests were performed at
the same time of day and in the fasting state . Stress studies
were conducted in the supine position and induced by a
constant load bicycle ergometer (Quinton) beginning at 0
work load for I min after which the work load was increased
to 200 kp-m . The work load was then kept constant at this
and each subsequent level for 4 min to allow time for cardia .,
imaging and hemodynamic equilibration . The bicycle proto-
col on the exposure days was designed to enable acquisition
of at least one image during stress with an additional study or
studies at submaximal work loads when the patient's exer-
cise capacity permitted . The same exercise protocol was
followed on each of the exposure days. At 4 min intervals,
the work load was increased in 50 to MIX) kp-m increments
until a maximal level was achieved.
Exercise was continued trotil rate o f the JUllooeing oc-
curred: angina that required cessation of exercise, fatigue
precluding further exercise, hypotension or plateau of blood
pressure despite an increase in work load
. Blood pressure
was measured by the cuff manometric technique before,
every 2 min during and each minute after exercise until
stable . A 12 lead ECG was recorded immediately before and
at each minute during exercise . Tracings were also obtained
each minute for z8 min after exercise and leads 11, V4- and
Vs
were continuously monitored during the study . Chest
pain was graded on a scale of I to 10, with 10 being the
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maximal pain previously experienced by the subject . A timer
was used to initiate the protocol and patients were instructed
to immediately inform the investigators of the onset and
resolution (If chest pain . These times were recorded and
used to calculate onset and duration of angina in seconds
.
The same observers measured blood pressure and recorded
the timing of symptoms on both exposure days .
Cardiac imaging
. Rest and exercise equilibrium radionu-
elide ventriculography was performed with a large fold of
view gamma camera (Elscint Apex 415) fitted with a general
purpose collimator. Images were acquired in the supine
position from the modified left anterior oblique projection
with the degree of angulation and caudal tilt selected to
optimally isolate the left ventricle (18,19) . A stable blood
pool label was created by intravenous administration of 2 to
3 ml of unlabeled stannous pyrophosphate into a peripheral
vein followed in 20 min by injection of 20 to 30 mCi of
technetium-99m pertechnetate . Imaging was continued at
rest until approximately 7 .5 million counts were obtained.
Exercise imaging began I min into each stage and lasted
for the remainder of that stage . All radionuclidc data
were stored on disk for subsequent analysis with pre-
viously validated software provided by Elscint
. Left
ventricular ejection fraction was calculated from the image
data with the use of a semiautomated region of interest
program and periventricular background subtraction method
(18.19).
Statistical considerations
. The research design for this
study had a crossover structure with separate randomization
schedules for patients who were on medication and for those
who were not. These schedules were balanced so that four
patients in each successive set of eight received air exposure
before carbon monoxide exposure and the remaining four in
the reverse order. Among the 30 patients included in the
study analysis, 14 underwent air exposure before carbon
monoxide exposure and 16 received carbon monoxide expo-
sure before air exposure .
The sample size of 30 patients was specified at the
beginning of the study . For a previous crossover study (15)
in our laboratory, the inclusion DIN patients provided >0 .90
statistical power for the comparison between air exposure
and carbon monoxide exposure at 4% carboxyhemoglobin
with respect to the change between rest and maximal ejec-
tion fraction . A difference between exposures of w5 U
change in ejection fraction was used there as the target for
the detection of significance with two-sided p s 0 .05. Similar
statistical power properties apply to the current study
through its inclusion of 30 patients .
Data analysis . The following variables were analyzed to
compare the air and carbon monoxide exposure days with
respect to patient experiences at rest and during exercise : I)
heart rate ; 2) systolic blood pressure; 3) heart rate x systolic
blood pressure ; 4) ECG-ST segment depression ; 5) peak
exercise work load ; 6) exercise duration ; 7) time to onset of
903
angina pectoris
. 8) duration of angina pectoris; 9) venous
carboxyhemoglobin level
; and 10) left ventricular electionn
fraction .
For descriptive purposes . the data for the respective
variables were summarized in terms of mean values and their
corresponding SE for the air exposure, the carbon monoxide
exposure and the difference between them. Statistical com-
parisons between the two exposure conditions were under-
taken primarily with the Wilcoxon signed rank statistic (20)
because of its applicability under minimal assumptions ;
paired t
tests were also determined . The appropriateness of
these methods was supported by the confirmation that day
effects and (exposure x dayl carryover effects were rela-
tively minimal on the basis of the appropriate nonparametric
procedures (21)
.
Some farther statistical attention mas given to lime to
onset of angina pectoris because four patients developed
angina only on the carbon monoxide day
. The experience of
these patients for not developing angina on the air day w'ts
taken into account with an actuarial method (22) . More
specifically, the information concerning time to angina for
each exposure was summarized in terms of the ratio for the
number of patients developing angina divided by the sum of
the durations of exercise for all patients; i.e ., the measure
reflects the number of incidents of angina per minute of
exercise time and thereby represents an incidence density
rat° (23). The comparison of the incidence density rates for
the two exposures was based on assessing the difference
between their logarithms relative to its SE (that is, through
the logarithm of the incidence density ratio) .
The analysis of exercise ejection fraction nteasarements
was undertaken in ways that appropriately accounted for the
complex aspects of imaging requirements and differences in
exercise duration on the study days . These factors created
discrepancies in 10 of the 30 study patients between the 2
exposure days in the timing of final ejection fraction mea-
surement and maximal exercise . On the basis of these
considerations, two analyses of peak exercise ejection frac-
tion were performed . The first analysis contrasted this
radionuclide variable on the 2 exposure days at the final
work loads regardless of whether or not they were matched .
A second comparison of maximal ejection fraction was mo4e
in the 24 patients with this measurement at the same peak
work load on both days .
Analysis of sabtrtaximal ejection fraction data
was per-
formed in 19 patients with more than one such measurement
on >I exposure day. In 13 patients, these data were avail-
able at submaximal exercise and matched work loads on
both exposure days. Because of differences in exercise
duration, the submaximal ejection fraction data did not
correspond to submaximal exercise in both air and carbon
monoxide sessions in six subjects .
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Table 1 . Individual Patient Data (n = 30) for Selected Exercise Measurements on the Air and
Carbon Monoxide Exposure Days
Results
Carboxyhemoglobin levels
. The mean rest carboxyhemo-
globin level was 1 .7 ± 0.1% on the carbon monoxide day and
slightly higher 1 .9 ± 0.1% on the air day (p < 0.011
. The
mean level obtained immediately after carbon monoxide
exposure wax 5 .9 ± 0
.1% and fell to 5 .2 ± 0.1% after
exercise in room air. (The mean difference between carboxy-
hemoglobin during exercise testing on the carbon monoxide
exposure day versus air exposure day was about 4 .0% 15 .6 to
1 .6%j
.) On the air day the carboxyhemoglobin concentration
dropped from 1
.9 z 0 .1 to 1 .6 t 0 .1% during chamber
exposure (p < 0 .01) and was 1
.6 ; 0 .1% after exercise .
Exercise-induced ischemia (Table 1)
. All 30 patients in-
cluded in the study analysis had evidence of ischemia during
exercise on at least one of the exposure days as manifested
by ST segment criteria (>I mm horizontal or downsloping
ST depression in 24 of 30), typical angina during exercise (25
CO = carbon monoxide. Extent CAD = number of major epicardial coronary arteries with at least one slenasis
070
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of 30) or an abnormal exercise ejection fraction response
(failure to increase 115 U from rest in 26 of 30)
.
Air exposure day
. Rest left ventricular ejection fraction
was in the normal range (?53%) in 20 of the 30 patients on
the air day and no patient had a value of <40% . Mean rest
left ventricular ejection fraction was 58 ± 1 .7% on the day of
air exposure and essentially did not change at peak exercise .
For 22 of the 30 patients, the change in ejection fraction from
rest to maximal exercise was <5 U on the air day
. Chest pain
consistent with angina developed in 21 of the 30 patients on
the air day. Time to onset of angina averaged 288 ± 36 s for
these 21 patients and chest pain was prolonged with a mean
duration of 484 ± 46 s
. Mean maximal ST segment depres-
sion was 1 .6 ± 0
.2 mm on the air day for the 22 patients
showing ? I mm of ST depression
.
Exercise air versus carbon monoxide exposure
. There was
no significant difference in rest heart rate between the
Subject
hem
CAD
rare,. Onset of
Angina(s)
Duration or
Exercise")
Time to
Significant ST
Depression(s)
Air Co Air CO
Air CO
270 285 - -
2267 m5 370 3txl -
21x1 175 325 301 240 1110
4 IRO
1911 2x1 2110 120 u0
R1 41
220 220 -
- 190 406
370 240 180
- 615
795 710 361
3"8 130 12.0 540 480 250 60
9 3 - -
345 320 240 300
0 585 505
1
.120 1 .020
360 420
II 3 (50 191 540 540 - -
12 625 6m ( .280 1 .170 - -
3 120 150 180 180 120 120
l4 - 360 325 720 490 4110 480
S 370 255 741 720 - -
16 I - - 780 780
- 600
I7 - - 7110 780 780
66D 300
R 550 545 780 780 -
660
19 3 228 230 868 840 600 660
21 I 168 130 505 330 122 120
21 125 200 510 550 480 -
__ - 277 335 1,02D 780 180 240
23 510 54D 3611 395 240
24 245 142
510 332 360 120
25 252 350 614 750
300 122
26 - - x40 1140 540
543
27 1 - 07D 1 .020 1 .020 783
720
28
- -
-
720 759 363 360
29
I 239 225 462 ,40 I&) 240
30
1 348 623 798 720 300 24D
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INDIVIDUAL SUBJECTS
Figure 2. Study data showing the difference in exercise duration
between the air and the carbon monoxide (CO) exposure day on the
Y axis and 30 individual su sects on the X axi, . In 10 aluectz there
was no change in exercise duration between the study day, .
exposure days (60 * 1 .8 beatsimin for air versus 60
.
1 .8
beatsimin for carbon monoxide) . Rest blood pressure was
slightly higher after air as compared with carbon monoxide
exposure 1157 ± 4.2 mm Hg for air versus 152 -- 4 .0 mm Hg
for carbon monoxide, p < 0.1)5) . The mean duration of
exercise was significantly longer after air exposure (626 - 511
s for air versus 585 ± 49 s for carbon monoxide . p = 0.02)
.
Only 5 of the 30 patients had longer exercise duration after
carbon monoxide compared with air exposure (Fig . 2). In 15
patients, exercise lasted longer on the air day and for 10 of
these patients- it was at least I min longer . There was a
difference in exercise duration of 69 + 35 s in favor of the air
day among the six study patients with three vessel disease .
Time to onset of angina was greater on the air day in 13 of
21 patients with this finding on both exposure days
. This
difference exceeded I min in 6 of the 13
. There was a
suggestive tendency for onset of angina to occur earlier on
the carbon monoxide day in the 21 subjects with this
symptom on both exposure days (288 *- 36 s for air versus
261 ± 34 s for carbon monoxide, p - 0.25) . The difference in
time to onset of angina between the air and carbon monoxide
days in the five study patients with three vessel disease and
this symptom on both days was 57 ± 56 s . In fosr patients .
angina developed during exercise only on the day of carbon
monoxide exposure; no patient had this symptom on the air
day alone . An actuarial method (22) directed at the ratio of
the proportion of patients with angina divided by the average
duration of exercise indicated that the patients were likely to
experience angina earlier during stress on the carbon mon-
oxide day (p < 0.05)
. There was no difference between the
study day in duration of angina (484 - 46 s for air versus 438
* 45 s for carbon monoxide for subjects with angina) . Also .
maximal ST segment depression (1.6 ± 0 .2 mm for air versus
1 .7 ± 0.2 mm for carbon monoxide for patients showing
I
mm of ST depression) and time to significant ST segment
An4Sts ET AL.
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depresson ( =I mm) (349
-
39 s for al -ver us 344 ; 45 s for
carbon monoxide) were similar for the two exposures .
(fo crow! blood pre.r.arre achieved during exercise did not
d41cr by exposure 1192
-
4.6 mm fig for air versus 139 - 5 .1
mm Hg for carbon monoxide) . There was a trend for
maxim ;d heart rate to he higher after carbon monoxide 1105
3 .7 beatsimin for air versus 108 - 3.5 beatsimin for carbon
Morn
safe
. p = (1.06) ; but maxi: nal rate-pressure Product
(20.389 ' 1080 for air versus 2'1515 - 1 .1)39 for carbon
monoxide)
and peak work load 612
-
28 versus 303 _` 26
kp-m) were indistinguishable on the'_ exposure days .
Radionuclide venirieutngraphy an air versus carbon mans-
aside
(Tables 2 and 31. Analysis of the radionuclide data
(Fig . 3) revealed no significant difference in rest post-
exposure left ventricular ejection fraction on the air and
carbon monoxide days (58 a- 1 .7 versus 58 - 1 .7, respec-
tively) . In the 19 patients with data available. the level of
suhmaximal ejection fraction was significantly higher after
air compared with carbon monoxide exposure 162 * .4
census 60
- 2
.4%, respectively
. p - 0
.05) . There was also a
significant difference in the change from rest to submaximal
ejection fraction between the 2 exposure days (1 .6 - I .65£
for air versus -1 .2 0 1 .6% for carbon monoxide . p = 0.05) .
Do, srn.r	i ferenee in
ntrtxinml eita 6 rr fraction after
tit
and rarhorr monoxide exposure among the 30 subjects
with these data available at matched or unmatched work
loads on the study days (57 -_ 2
.2% for air versus 57 -- 2 . I I
for carbon monoxide)
. No difference in peak ejection frac-
tion was found among the 24 patients with this measurement
at similar work loads on the 2 exposure days (57
-
2 .5% for
air versus 57 - 2 .5% for carbon monoxide)
. The difference in
change in peak ejection fraction between the air and carbon
monoxide clays was 5 .4 ± 3 .0% for the 5 of these 24 study
patients with three vessel disease .
Impaired exercise performance on carbon monoxide expo-
sure- The study data reported here are the first to demon-
strate impairment of exercise ventricular function due to low
level exposure to carbon monoxide in patients with isehemic
heart disease . Left ventricular performance, as assessed by
radionuclide ejection fraction measurement, was reduced
during exercise after exposure to carbon monoxide com-
pared with air . In addition . other measurements indicated
that inhalation of this compound sufficient to produce a 6%
carboxyhemoglobin plasma level was associated with a
reduction in exercise performance and aggravation of symp-
toms . Exercise duration was significantly shorter after car-
bon monoxide than after air exposure
. There was a trend for
an earlier onset of angina after inhalation of this compound
among patients with this symptom on both exposure days
.
Analysis by actuarial methods demonstrated that the timing
of this end point occurred earlier during exercise after
carbon monoxide exposure compared with air exposure .
Although the changes we observed in exercise perfor-
mance between the air and carbon monoxide days were
906
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Table 2
. Individual Patient Data (n = 30) for Selected Radionuclide Measurements on the Air and
Carbon Monoxide Exposure Days
'Maximal LVEF nat taken a1 peak work load . Subsets have the following definitions : subset A consists of 13
patients with both submaximal and maximal exercise at matched work loads; subset B consists of six patient with
submaximal exercise at matched work loads on both exposure days but with a corresponding maximal exerise
sing far posure : subset C consists of II patients with maximal exercise at matched work loads but with
submaximal
exe expos
rcise m issing. CO = carbon monoxide : LVEF = left venfriculm- ejection friction.
significant, in the group as a whole they were not severe .
Peak left ventricular ejection fraction was unaltered and the
mean difference in exercise duration was <I min . This
finding suggests that a 6% carboxyhemoglobin level is near
the threshold necessary for adverse effects on exercise
performance from an acute exposure to carbon monoxide
among a broad group of patients with ischemic heart disease .
It is important to note that deleterious effects of this expo-
sure level were more pronounced in individual patients and
especially in the small cohort of patients with three vessel
coronary disease .
Enhanced hypoxia . These subjective and objective in-
dexes of exercise performance suggest that a
6%
blood
carboxyhemoglobin level is sufficient to impair exercise
myocardial oxygenation in ischemic heart disease . Total
IACC V. 12. No.4
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duration of exercise has been related by the present inves-
tigators (24) and others (25,26) to the development and
magnitude of exercise-induced myocardial ischemia . Early
radionuclide studies (27,28) linked left ventricular ejection
fraction response during exercise to the presence or absence
of myocardial ischemia (27,28). Since subsequent investiga-
tion had demonstrated that functional response is not en-
tirely a reflection of ischemia, we carefully considered other
factors that could have influenced our exercise ejection
fraction results . Primary myocardial and valvular heart
disease alone may produce exercise left ventricular dysfunc-
tion (29,30), so patients with these disorders were excluded
from the protocol . Patients with coronary artery disease and
marked rest cardiac dysfunction may have a poor ventricular
response to exercise even in the absence of ischemia (31,32)
.
LVE ., Rest
Sohmaxim
:d
LVEF Maximal LVEF
Subject Sub- Air CO Air CO Air CO
C 71 66
70 73
C 49 46
53' 46
3 C 41 45 36
40
C 62 62
63 66
C 411 49
42 44
A
72
76 71 fib 5s 66
A 56 60 54 59 52 62
A 59 69 67 69 71 70
C 59 56 60 59
A 57 50 66 52 67 57
A 48 52 54 52 53 55
B 48 53 64 58 57
C 47 49 30
14 B v4 63 68 67 76
15 C 42 42 4? 39 45
A 63 6l 6-
58
57
50
A 65 58 66
57 r;0 60
B 60 57 56
54
A 49 50 53 47 51
20 C 56 55
.t9'
44
21 C 53 53 54 9 54
22 B 61 67 48 47 St
23
B 62 69 63 59
65
24
C
60 73
64
25 B 60 51 49 49 55
26 A 70
68
75 75 74' 72'
27 A 76 77 86 87
86
82
28 A 50 56 54 55 50 57
29 A 54 48 52 45 51
30
A
72 70 73 72
69 70
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However, the subjects we studied had a mean rest ejection
fraction within the normal range . Although female gender
may be associated with poor ejection fraction response to
exercise (33), the majority of the present study patients were
male . Finally, the present study design compared exercise
ejection fraction response after air and carbon monoxide
exposure in the same subject . The work of Hecht et al . (34)
suggests that if paired exercise radionuclide ventriculograms
are obtained in a group of patients under similar clinical
conditions, any differences in response between the two
sessions should be minor and statistically insignificant .
These considerations suggest that the greater exercise
myocardial dysfunction after carbon monoxide Irns due to a
noticeffect of this compound on cardiac oxygenation . This
result is consistent with the substantial impact on tissue
oxygen delivery that occurs from relatively small elevations
in carboxyhemoboxyhemoglobin concentration (1
.41
. The
high affinity of hemoglobin for carbon monoxide directly
reduces oxygen carrying capacity by displacing bound oxy-
gen . At the tissue level, a more profound effect, greater than
that expected r. Am direct displacement occurs
. owing to the
Figure 3. Study data showing the difference in ejection fraction IEFt
response at submaximal exercise between the air and carbon mon-
oxide days on the Y axis and 19 individual subjects on the X axis .
Abbreviations as in Figure 2 . Two subjects had no difference in
submaximal ejection fraction response on the two study days .
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increase in affinity of hemoglobin for the oxygen that re-
mains.
Potential limitations of the study . Our results did not
support a deleterious influence of this blood level of ear-
boxyhemoglobin on maximal exercise left ventricular func-
tion . Several factors related to the study design and the
constraints of the imaging protocol likely contributed to this
finding . Differences in exercise duration that could have
independently influenced peak function prevented compari-
son of maximal ejection fraction on the air and carbon
monoxide days in 10 patients. Restriction of the analysis to
the 10 patients whose peak work load and ejection fraction
data coincided on the 2 exposure days was not possible . Use
of these subjects alone would have introduced a bias because
requiring identical periods of exercise on both days selects a
group that may have had less carbon monoxide effect
.
Because equilibrium imaging requires several minutes for
data acquisition, it is also possible that differences in ven-
tricular function occurring toward the end of exercise could
have been missed.
Finally . we investigated a broad spectrum of patients with
coronary artery disease at ,srget blood levels of carboxyhe-
moglobin expected to be close to threshold for cardiovascu-
lar effects . In this setting, it is unclear whether functional
differences would be seen at both maximal and submaximal
exercise
. Our study does not rule out the potential of greater
peak exercise dysfunction after carbon monoxide compared
with air exposure at higher levels of carboxyhemoglobin or
in patients with more severe ischemic heart disease
. Al-
though only suggestive because of the small numbers in-
volved . our study data in patients with three vessel coronary
disease were consistent with this latter possibility .
The great nugority of patients acre taking anhanginal
medications at rite rime of study . Although these drugs had
the potential to mask the effects of carbon monoxide expo-
sure
. such masking did not occur . Further, the inclusion of
patients on such medication improves our understanding of
the impact of carbon monoxide exposure in the broad range
of patients with ischemic heart disease . Our data cannot .
however. rule out the possibility that even greater impair-
Varamn Duff
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meet of exercise performance might have occurred at this
level of carboxyhemoglobin in patients not taking medica-
tions to control angina.
Smokers were excluded feats the present investigations
so that the specific effect of carbon monoxide inhalation
could he studied . Recent data (35) indicate that nicotine may
act as a direct coronary vasoconstrictor and produce myo-
cardial ischemia
. Thus, active or passive smoking sufficient
to produce the same level of carboxyhemoglobin attained in
this study may be associated with greater impairment of
exercise performance .
The present study gram," lrns biased toward patients with
the symptom of nuginn, this end point being found in 25
patients during the course of the study . Recent investigation
(36) has documented the common occurrence of transient
episodes of myocardial ischemia without associated chest
pain . The physiologic effects of carbon monoxide exposure in
patients with predominantly silent or with mixed symptomatic
and silent ischemia are not addressed by the present work
.
Previous studies. Our studies represent the largest patient
experience concerning the toxic effects of carbon monoxide
on exercise performance in ischemic heart disease . This
work suggests that the threshold for an adverse effect of
blood carboxyhemoglobin on exercise performance in gen-
eral populations of patients with ischemic heart disease is
between 4 and 6%. Our studies differ in design and results
when compared with much previous work on the adverse
effects of acute elevation of this compound in coronary
artery disease
. Aronow and Rokaw (7) studied the influence
of carbon monoxide exposure sufficient to attain 7 .8% car-
boxyhemoglobin an exercise performance in 10 patients with
ischemic disease . Although the exposure sequence was
randomized, the study was not blinded . The protocol design
included smokers with only a 12 h interval between the
protocol and cessation of smoking. The unblinded nature of
the study and the inclusion of smokers could have indepen-
dently influenced the observed association between exercise
performance and carbon monoxide inhalation . Aronow and
Isbell (8) studied the toxicity of carbon monoxide in 10
patients with angina with a blinded study design . Although
no patient was a current smoker
. the time between cessation
of cigarette use and performance of the protocol was not
given . The patients had undergone a minimum of 10 previous
exercise tests and they had a consistent time to onset of
chest pain . Anderson et al
. (13) reported an adverse effect of
low level carbon monoxide exposure in patients with ische-
mic heart disease . Their small study population of 10 pa-
tients included smokers and utilized a somewhat unnrthodnv
exposure protocol allowing "rest" periods interspersed with
exposure to gases through a mask
. The study methods
suggest that the subjects were not taking anti-anginal medi-
cations during the protocol period . Such design differences
could have contributed to the disparities between these latter
two studies and the work from our laboratory
. In 1981,
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Aronow (14) reported an adverse effect of 2% carhoxyhemo-
globin on exercise performance in 15 patients with angina. In
contrast to studies from our laboratory, only 8 of the
subjects had evidence of ST depression during exercise to
corroborate the ischemic origin of their chest pain .
None of the previous studies of which we are aware have
included measurement of ventricular function to validate the
ischemic nature of the subjective end point of time to onset
of chest pain
. The studies conducted by our group have
incorporated stringent design features including the use of an
exposure chamber to enhance the double blind nature of the
sessions . Our studies have involved a wide cross section of
patients with ischemic heart disease rather than being re-
stricted to those with reproducible exercise-induced chest
pain . We have included patients taking anti-anginal medica-
h ass and with varying severity of underlying coronary artery
disease. These additional factors likely contribute to the
difference in the threshold for carbon monoxide toxicity
suggested by the present and prior work.
Health effects . The issue of cardiac toxicity related to the
inhalation of carbuu monoxide remains of interest despite
current regulations designed to limit environmental exposure
to this compound. The population at risk is large ; there are
estimated to be 2 million patients with coronary artery
disease complicated by angina in the United States today
(371 who world be at risk from carbon monoxide exposure.
Recent reports QD do document a fall in ow average
ambient carbon monoxide level in most urban areas from
1977 to 1986 (38) . In sites that conform to the national air
quality standard of an average of <9 ppm carbon monoxide
for an 8 h period or <35 ppm for a I h period, achievement of
carboxyhemoglobin levels similar to those examined in this
study would be unlikely
. However, in a number of specific
environmental situations such as tunnels, houses with defec-
tive gas furnaces and closed automobiles during heavy free-
way traffic, it would be possible to achieve the levels of
carboxyhemoglobin investigated here . In addition, patients at
risk who continue to smoke often experience levels of at least
the magnitude investigated in the present study (39) . The
available data suggest that despite long-term exposure, dele-
terious effects of acute carbon monoxide exposure persist in
those who use cigarettes.
Conclusions. The study results reported here indicate
that acute exposure to carbon monoxide sufficient to pro-
duce a plasma carboxyhemoglobin level of 6% is associated
with significant impairment of exercise performance in pa-
tients with ischemic heart disease . The difference in ventric-
ular performance observed aftercar boo monoxide compared
with air exposure provides the first description of a direct
toxic effect of this compound on exercise ventricular func-
tion . The most likely explanation for these deleterious ef-
fects of carbon monoxide is a worsening of myocardial
ischemia due to impaired oxygen delivery to working myo-
cardium .
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